Sulfadiazine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Eon Labs, Inc.. The primary component is Sulfadiazine.
| Product ID | 0185-0757_4435aed7-872c-4439-b5d7-4abd212f4a1e |
| NDC | 0185-0757 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sulfadiazine |
| Generic Name | Sulfadiazine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1994-07-29 |
| Marketing End Date | 2024-05-31 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA040091 |
| Labeler Name | Eon Labs, Inc. |
| Substance Name | SULFADIAZINE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Sulfonamide Antibacterial [EPC],Sulfonamides [CS] |
| NDC Exclude Flag | N |
| Marketing Start Date | 1994-07-29 |
| Marketing End Date | 2024-05-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA040091 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1994-07-29 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040091 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-05-22 |
| Marketing End Date | 2017-10-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040091 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1994-07-29 |
| Marketing End Date | 2017-12-31 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| SULFADIAZINE | 500 mg/1 |
| SPL SET ID: | 10549cba-9c15-4d2e-a68c-5afbc178591d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0185-0757 | Sulfadiazine | Sulfadiazine |
| 42806-757 | SULFADIAZINE | sulfadiazine |